Fujian South Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ACETYLCYSTEINE, with a corresponding US DMF Number 37947.
Remarkably, this DMF maintains an Active status since its submission on June 26, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 18, 2023, and payment made on July 19, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II